These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 28729089

  • 1. Choreiform dyskinesias following levodopa treatment of parkinsonism due to osmotic demyelination syndrome.
    de Souza A, de Souza RJ.
    Parkinsonism Relat Disord; 2017 Oct; 43():120-121. PubMed ID: 28729089
    [No Abstract] [Full Text] [Related]

  • 2. Hemiparkinsonism and levodopa-induced dyskinesias after focal nigral lesion.
    Růzicka E, Urgosík D, Jech R, Roth J, Vymazal J, Mecír P, Vladyka V.
    Mov Disord; 2005 Jun; 20(6):759-62. PubMed ID: 15782419
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Extrapontine Myelinolysis and Reversible Parkinsonism After Hyponatremia Correction in a Case of Pituitary Adenoma: Hypopituitarism as a Predisposition for Osmotic Demyelination.
    Perikal PJ, Jagannatha AT, Khanapure KS, Furtado SV, Joshi KC, Hegde AS.
    World Neurosurg; 2018 Oct; 118():304-310. PubMed ID: 30055367
    [Abstract] [Full Text] [Related]

  • 7. HIV-associated Parkinsonism with levodopa-induced dyskinesia and response to highly-active antiretroviral therapy.
    Kobylecki C, Silverdale MA, Varma A, Dick JP, Kellett MW.
    Mov Disord; 2009 Dec 15; 24(16):2441-2. PubMed ID: 19908326
    [No Abstract] [Full Text] [Related]

  • 8. On the coexistence of parkinsonism and tardive dyskinesia.
    Fann WE, Lake CR.
    Dis Nerv Syst; 1974 Jul 15; 35(7):324-6. PubMed ID: 17894090
    [No Abstract] [Full Text] [Related]

  • 9. α7 nicotinic receptor agonists reduce levodopa-induced dyskinesias with severe nigrostriatal damage.
    Zhang D, McGregor M, Bordia T, Perez XA, McIntosh JM, Decker MW, Quik M.
    Mov Disord; 2015 Dec 15; 30(14):1901-1911. PubMed ID: 26573698
    [Abstract] [Full Text] [Related]

  • 10. l-Dopa-free learned dyskinetic behavior in a Parkinson's primate model.
    Li Q, Fernagut PO, Bezard E.
    Mov Disord; 2019 Aug 15; 34(8):1237. PubMed ID: 31083822
    [No Abstract] [Full Text] [Related]

  • 11. Levodopa-responsive parkinsonism in probable extrapontine myelinolysis of the mesencephalon.
    Toft M, Dietrichs E.
    Mov Disord; 2011 Oct 15; 26(12):2180-1. PubMed ID: 22021157
    [No Abstract] [Full Text] [Related]

  • 12. Dramatic Response to Pramipexole in Delayed-Onset Parkinsonism from Osmotic Demyelinating Syndrome.
    Han SC, Katus L, Frucht S.
    Tremor Other Hyperkinet Mov (N Y); 2020 Jun 16; 10():9. PubMed ID: 32775023
    [Abstract] [Full Text] [Related]

  • 13. Levodopa-induced dyskinesias are associated with transient down-regulation of cAMP and cGMP in the caudate-putamen of hemiparkinsonian rats: reduced synthesis or increased catabolism?
    Sancesario G, Morrone LA, D'Angelo V, Castelli V, Ferrazzoli D, Sica F, Martorana A, Sorge R, Cavaliere F, Bernardi G, Giorgi M.
    Neurochem Int; 2014 Dec 16; 79():44-56. PubMed ID: 25452081
    [Abstract] [Full Text] [Related]

  • 14. [Influence of hemantane in injectable dosage form on levodopa-induced dyskinesia in rats with model parkinsonian syndrome].
    Kapitsa IG, Ivanova EA, Kokshenev II, Nepoklonov AV, Val'dman EA, Voronina TA.
    Eksp Klin Farmakol; 2014 Dec 16; 77(5):3-5. PubMed ID: 25033563
    [Abstract] [Full Text] [Related]

  • 15. Amantadine reduces levodopa-induced dyskinesias in parkinsonian monkeys.
    Blanchet PJ, Konitsiotis S, Chase TN.
    Mov Disord; 1998 Sep 16; 13(5):798-802. PubMed ID: 9756148
    [Abstract] [Full Text] [Related]

  • 16. Levodopa-induced dyskinesia and rotational behavior in hemiparkinsonian rats: independent features or components of the same phenomenon?
    Konitsiotis S, Tsironis C.
    Behav Brain Res; 2006 Jun 30; 170(2):337-41. PubMed ID: 16621050
    [Abstract] [Full Text] [Related]

  • 17. L-Dopa response, choreic dyskinesia, and dystonia in Perry syndrome.
    Dulski J, Cerquera-Cleves C, Milanowski L, Kwiatek-Majkusiak J, Koziorowski D, Ross OA, Pentela-Nowicka J, Sławek J, Wszolek ZK.
    Parkinsonism Relat Disord; 2022 Jul 30; 100():19-23. PubMed ID: 35691177
    [Abstract] [Full Text] [Related]

  • 18. Levodopa-induced dyskinesia in a patient who has normal presynaptic dopaminergic neurons.
    Sunwoo MK, Kim KM, Hong JY, Sohn YH, Lee PH.
    Mov Disord; 2013 Jul 30; 28(8):1152-3. PubMed ID: 23386570
    [No Abstract] [Full Text] [Related]

  • 19. Emergencies in parkinsonism: akinetic crisis, life-threatening dyskinesias, and polyneuropathy during L-Dopa gel treatment.
    Onofrj M, Bonanni L, Cossu G, Manca D, Stocchi F, Thomas A.
    Parkinsonism Relat Disord; 2009 Dec 30; 15 Suppl 3():S233-6. PubMed ID: 20082998
    [Abstract] [Full Text] [Related]

  • 20. Predicting Long-Term Outcome of Patients of Early Parkinsonism with Acute Levodopa Challenge Test.
    Acharya M, Banerjee S, Chatterjee A, Mukherjee A, Biswas S, Gangopadhyay G, Biswas A.
    Neurol India; 2021 Dec 30; 69(2):430-434. PubMed ID: 33904468
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.